Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Country Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Key Opportunities Prioritized
5.2 Market Dynamics
5.2.1 Rising Adoption Of Radiotherapy
5.2.2 Technological Advancements In Radiotherapy
5.2.3 Rising Prevalence Of Cancer
5.2.4 Increase In Healthcare Expenditure
5.2.5 Favorable Reimbursement Scenario
5.3 Market Restraint Analysis
5.3.1 Lack Of Skilled Radiotherapy Professionals
5.3.2 Adverse Effects Of Radiotherapy
5.4 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
5.5 Porter’s Five Forces Analysis
5.6 Regulatory Framework
Chapter 6 The U.S. Radiation Oncology Market - Segment Analysis, By Type, 2016 - 2027 (USD Million)(Volume, Number Of Units)
6.1 The U.S. Radiation Oncology Market: Type Movement Analysis
6.2 External Beam Radiation Therapy
6.2.1 External Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.2.2 external Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.3 Electron-Emitting High Energy Linear Accelerators
6.2.3.1 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (USD Million)
6.2.3.2 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4 Compact Advanced Radiotherapy Systems
6.2.4.1 Compact Advanced Radiotherapy Systems Market, 2016 - 2027 (USD Million)
6.2.4.2 compact Advanced Radiotherapy Systems Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4.3 Cyberknife
6.2.4.3.1 Cyberknife Market, 2016 - 2027 (USD Million)
6.2.4.4 Gamma Knife
6.2.4.4.1 Gamma Knife Market, 2016 - 2027 (USD Million)
6.2.4.5 Tomotherapy
6.2.4.5.1 Tomotherapy Compact Market, 2016 - 2027 (USD Million)
6.2.5 Proton Therapy
6.2.5.1 Proton Therapy Market, 2016 - 2027 (USD Million)
6.2.5.2 Proton Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.5.3 Cyclotron
6.2.5.3.1 Cyclotron Market, 2016 - 2027 (USD Million)
6.2.5.4 Synchrotron
6.2.5.4.1 Synchrotron Market, 2016 - 2027 (USD Million)
6.3 Internal Beam Radiation Therapy
6.3.1 Internal Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.2 Internal Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3 Brachytherapy
6.3.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3.3 Seeds
6.3.3.3.1 Seeds Market, 2016 - 2027 (USD Million)
6.3.3.4 Applicators And After-Loaders
6.3.3.4.1 Applicators And After-Loaders Market, 2016 - 2027 (USD Million)
6.3.3.4 Electronic Brachytherapy
6.3.3.4.1 Electronic Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.4 Systemic Beam Radiation Therapy
6.3.4.1 Systemic Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.5 Others
6.3.5.1 Others Market, 2016 - 2027 (USD Million)
Chapter 7 The U.S. Radiation Oncology Market - Segment Analysis, By Technology, 2016 - 2027 (USD Million)(Volume, Number Of Units)
7.1 The U.S. Radiation Oncology Market: Technology Movement Analysis
7.2 External Beam Radiation Therapy (Ebrt)
7.2.1 Ebrt Market, 2016 - 2027 (USD Million)
7.2.2 Ebrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.3 Image-Guided Radiation Therapy (Igrt)
7.2.3.1 Igrt Market, 2016 - 2027 (USD Million)
7.2.3.2 Igrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.4 Intensity Modulated Radiotherapy (Imrt)
7.2.4.1 Imrt Market, 2016 - 2027 (USD Million)
7.2.4.2imrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5 Stereotactic Radiotherapy
7.2.5.1 Stereotactic Radiotherapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5.2stereotactic Radiotherapy Market, 2016 - 2027 (USD Million)
7.2.6 Proton Beam Therapy
7.2.6.1 Proton Beam Therapy Market, 2016 - 2027 (USD Million)
7.2.6.2proton Beam Therapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.7 3d Conformal Radiotherapy (3d-Crt)
7.2.7.1 3d-Crt Market, 2016 - 2027 (USD Million)
7.2.7.2 3d-Crt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.8 Volumetric Modulated Arc Therapy (Vmat)
7.2.8.1 Vmat Market, 2016 - 2027 (USD Million)
7.2.8.2vmat Market, 2016 - 2027 (Volume, Number Of Procedures)
7.3 Brachytherapy
7.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.3 Low Dose Rate (Ldr) Brachytherapy
7.3.3.1 Ldr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.3.2ldr Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.4 High Dose Rate (Hdr) Brachytherapy
7.3.4.1 Hdr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.4.2 hdr Brachytherapmarket, 2016 - 2027 (Volume, Number Of Units)
Chapter 8 The U.S. Radiation Oncology Market - Segment Analysis, By Application, 2016 - 2027 (USD Million)(Volume, Number Of Procedures)
8.1 The U.S. Radiation Oncology Market: Application Movement Analysis
8.2 External Beam Radiation Therapy (Ebrt)
8.2.1 Prostate Cancer
8.2.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.2.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.2 Breast Cancer
8.2.2.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.2.2.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.3 Lung Cancer
8.2.3.1 Lung Cancer Market, 2016 - 2027 (USD Million)
8.2.3.2 Lung Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.4 Head And Neck Cancer
8.2.4.1 Head And Neck Cancer Market, 2016 - 2027 (USD Million)
8.2.4.2 Head And Neck Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.5 Colorectal cancer
8.2.5.1 Colorectal Cancer Market, 2016 - 2027 (USD Million)
8.2.5.2 Colorectal Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.6 Others
8.2.6.1 Others Market, 2016 - 2027 (USD Million)
8.3 Internal Beam Radiation Therapy
8.3.1 Prostate Cancer
8.3.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.3.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.2 Gynecologic Cancer
8.3.2.1 Gynecologic Cancer Market, 2016 - 2027 (USD Million)
8.3.2.2 Gynecologic Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.3 Breast Cancer
8.3.3.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.3.3.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures N)
8.3.4 Cervical Cancer
8.3.4.1 Cervical Cancer Market, 2016 - 2027 (USD Million)
8.3.4.2 Cervical Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.5 Penile Cancer
8.3.5.1 Penile Cancer Market, 2016 - 2027 (USD Million)
8.3.5.2 Penile Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.6 Others
8.3.6.1 Others Market, 2016 - 2027 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategic Framework
9.2 Company Profiles
9.2.1 Varian Medical Systems, Inc.
9.2.1.1 Company Overview
9.2.1.2 Financial Performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Elekta Ab
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Accuray Inc.
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 C.R. Bard, Inc.
9.2.4.1 Company Overview
9.2.4.2 Financial Performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Mevion Medical Systems
9.2.5.1 Company Overview
9.2.5.2 Product Benchmarking
9.2.5.3 Strategic Initiatives
9.2.6 Ion Beam Applications (Iba).
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Curium
9.2.7.1 Company Overview
9.2.7.2 Product Benchmarking
9.2.8 Nordion Inc.
9.2.8.1 Company Overview
9.2.8.2 Product Benchmarking
9.2.8.3 Strategic Initiatives
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Key Company Market Share Analysis, 2019
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.4.2 Competitive Dashboard Analysis
9.5 Private Companies
9.5.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
9.5.2 Geographical Network Map
List of Tables
Table 1 List of secondary sources
Table 2 List of reimbursement for radiation therapy
Table 3 Reimbursement for IMRT services
Table 4 Reimbursement for IGRT services
Table 5 List of key distributors
Table 6 List of key emerging companies /technology disruptors/innovators
Table 7 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (USD Million)
Table 8 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (Volume in units)
Table 9 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (USD Million)
Table 10 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (Volume in units)
Table 11 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (USD Million)
Table 12 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (Volume in units)
Table 13 The U.S. Compact Advanced Radiotherapy Systems Market, by Product Type, 2016 - 2027 (USD Million)
Table 14 The U.S. Proton Therapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 15 The U.S. Brachytherapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 16 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (USD Million)
Table 17 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (Volume (number of procedures))
Table 18 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (USD Million)
Table 19 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (Volume in units)
Table 20 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 21 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 22 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 23 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 24 The U.S. Brachytherapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
List of Figures
Fig. 1 The U.S. radiation oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 The U.S. radiation oncology market snapshot
Fig. 10 The U.S. radiation oncology market segmentation
Fig. 11 Key market opportunities
Fig. 12 The U.S. radiation oncology market driver impact
Fig. 13 New cancer cases in 2020
Fig. 14 Cancer deaths in 2020
Fig. 15 The U.S. radiation oncology market restraint impact
Fig. 16 SWOT analysis, by factor (political & legal economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 The U.S. radiation oncology market: Type outlook and key takeaways
Fig. 19 The U.S. radiation oncology market: Type movement analysis
Fig. 20 External beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 21 External beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 22 Electron-emitting high energy linear accelerators market, 2016 - 2027 (USD Million)
Fig. 23 Electron-emitting high energy linear accelerators market, 2016 - 2027 (Volume, number of units)
Fig. 24 Compact advanced radiotherapy systems market, 2016 - 2027 (USD Million)
Fig. 25 Compact advanced radiotherapy systems market, 2016 - 2027 (Volume, number of units)
Fig. 26 CyberKnife market, 2016 - 2027 (USD Million)
Fig. 27 Gamma Knife market, 2016 - 2027 (USD Million)
Fig. 28 Tomotherapy market, 2016 - 2027 (USD Million)
Fig. 29 Proton therapy market, 2016 - 2027 (USD Million)
Fig. 30 Proton therapy market, 2016 - 2027 (Volume, number of units)
Fig. 31 Cyclotron market, 2016 - 2027 (USD Million)
Fig. 32 Synchrotron market, 2016 - 2027 (USD Million)
Fig. 33 Internal beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 34 Internal beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 35 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 36 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 37 Seeds market, 2016 - 2027 (USD Million)
Fig. 38 Applicators and after-loaders market, 2016 - 2027 (USD Million)
Fig. 39 Electronic brachytherapy market, 2016 - 2027 (USD Million)
Fig. 40 Systemic beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 41Systemic beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 42 Others market, 2016 - 2027 (USD Million)
Fig. 43 The U.S. radiation oncology market: Technology outlook and key takeaways
Fig. 44 The U.S. radiation oncology market: Technology movement analysis
Fig. 45 EBRT market, 2016 - 2027 (USD Million)
Fig. 46 EBRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 47 IGRT market, 2016 - 2027 (USD Million)
Fig. 48 IGRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 49 IMRT market, 2016 - 2027 (USD Million)
Fig. 50 IMRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 51 Stereotactic radiotherapy market, 2016 - 2027 (USD Million)
Fig. 52 Stereotactic radiotherapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 52 Proton beam therapy market, 2016 - 2027 (USD Million)
Fig. 53 Proton beam therapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 54 3D-CRT market, 2016 - 2027 (USD Million)
Fig. 55 3D-CRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 56 VMAT market, 2016 - 2027 (USD Million)
Fig. 57 VMAT market, 2016 - 2027 (Volume, number of procedures)
Fig. 58 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 59 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 60 LDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 61 LDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 62 HDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 63 HDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 64 The U.S. radiation oncology market: Application outlook and key takeaways
Fig. 65 The U.S. radiation oncology market: Application movement analysis
Fig. 66 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 67 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 68 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 69 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 70 Lung cancer market, 2016 - 2027 (USD Million)
Fig. 71 Lung cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 72 Head and neck cancer market, 2016 - 2027 (USD Million)
Fig. 73 Head and neck cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 74 Colorectal cancer market, 2016 - 2027 (USD Million)
Fig. 75 Colorectal cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 76 Others market, 2016 - 2027 (USD Million)
Fig. 77 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 78 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 79 Gynecological cancer market, 2016 - 2027 (USD Million)
Fig. 80 Gynecological cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 81 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 82 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 83 Cervical cancer market, 2016 - 2027 (USD Million)
Fig. 84 Cervical cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 85 Penile cancer market, 2016 - 2027 (USD Million)
Fig. 86 Penile cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 87 Others market, 2016 - 2027 (USD Million)
Fig. 88 Strategic Framework
Fig. 89 Company market share analysis, 2019
Fig. 90 Company market position analysis (Total revenue & operating profit)
Fig. 91 Company market position analysis (Profit margin)
Fig. 92 Competitive dashboard analysis
Fig. 93 Geographical network map